Discover how peptide-based biologics are transforming autoimmune disease treatment by offering targeted, gut-selective immune modulation. Learn how vedolizumab’s peptide-engineered design blocks α4β7 integrin to treat ulcerative colitis and Crohn’s disease while preserving systemic immune function.
- admin@condrug.com
- Mon - Sat: 8.00 am - 7.00 pm
We develop solutions for your clinical data needs